Skip to content
TrialScanner

NCT07205081

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

Phase 1CompletedATTOLead

Registry record

Lead sponsor
Attovia Therapeutics Inc
Conditions
Normal Volunteers; Atopic Dermatitis (AD); Atopic Eczema; Atopic Eczema/Dermatitis (Non-Specific)
Primary completion
Aug 13, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT07205081 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.